Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 33, Issue 10, 2015, Pages 679.e1-679.e21

  Vidal, Elisa ^a   Cervera, Carlos ^b   Cordero, Elisa ^c   Armiñanzas, Carlos ^d   Carratalá, Jordi ^e   Cisneros, José Miguel ^c   Fariñas, M Carmen ^d   López Medrano, Francisco ^f   Moreno, Asunción ^b   Muñoz, Patricia ^g   Origüen, Julia ^f   Sabé, Núria ^e   Valerio, Maricela ^g   Torre Cisneros, Julián ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIFUNGAL AGENT; AZATHIOPRINE; BASILIXIMAB; CEFUROXIME; CIPROFLOXACIN; CLOXACILLIN; COLISTIN; COTRIMOXAZOLE; CYCLOSPORIN; DEOXYCHOLIC ACID; EVEROLIMUS; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; FLUCYTOSINE; FOSFOMYCIN; IMMUNOSUPPRESSIVE AGENT; LINEZOLID; MYCOPHENOLIC ACID; NITROFURANTOIN; OKT 3; PIVMECILLINAM; PREDNISONE; QUINOLONE DERIVATIVE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORICONAZOLE; ANTIINFECTIVE AGENT;

ACUTE PYELONEPHRITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIURIA; CANDIDURIA; CONSENSUS; CYSTITIS; ESCHERICHIA COLI; GRAFT RECIPIENT; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INVASIVE CANDIDIASIS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MINIMUM INHIBITORY CONCENTRATION; PARTIAL HEPATECTOMY; PERCUTANEOUS DRAINAGE; PROSTATITIS; RECOMMENDED DRUG DOSE; RENAL GRAFT DYSFUNCTION; REOPERATION; RISK FACTOR; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; UROGENITAL TRACT CANCER; UROLITHIASIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ASYMPTOMATIC DISEASE; CONSENSUS DEVELOPMENT; DRUG INTERACTION; FEMALE; GRAFT REJECTION; IMMUNOCOMPROMISED PATIENT; MALE; MICROBIOLOGY; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINE; RECURRENT DISEASE; URINARY TRACT INFECTIONS;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ASYMPTOMATIC DISEASES; BACTERIURIA; DRUG INTERACTIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSTATITIS; RECURRENCE; RISK FACTORS; TRANSPLANT RECIPIENTS; URINARY TRACT INFECTIONS;

EID: 84952874745     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2015.03.024     Document Type: Article

References (218)

1. G.J. Alangaden, R. Thyagarajan, S.A. Gruber, K. Morawski, J. Garnick, J.M. El-Amm, and et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors Clin Transplant 20 2006 401 409
2. G. Alangaden Urinary tract infections in renal transplant recipients Curr Infect Dis Rep 9 2007 475 479
3. G. Pellé, S. Vimont, P.P. Levy, A. Herting, N. Ouali, C. Chassin, and et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function Am J Transplant 7 2007 899 907
4. E. Vidal, J. Torre-Cisneros, M. Blanes, M. Montejo, C. Cervera, J.M. Aguado, and et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort Transpl Infect Dis 14 2012 595 603
5. B. Valera, M.A. Gentil, V. Cabello, J. Fijo, E. Cordero, and J.M. Cisneros Epidemiology of urinary infections in renal transplant recipients Transplant Proc 38 2006 2414 2415
6. J.M. Herrero-Martínez, C. Lumbreras, A. Manrique, R. San-Juan, A. Garcia-Reyne, F. Lopez-Medrano, and et al. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation Clin Microbiol Infect 19 2013 1132 1139
7. M.A. Kish Infectious Diseases Society of America Guide to development of practice guidelines Clin Infecy Dis Off Publ Infect Dis Soc Am 32 2001 851 854
8. AGREE Next Steps Consortium The AGREE instrument II [Electronic version] 2009 Retrieved from www.agreetrust.org
9. L.E. Nicolle, S. Bradley, R. Colgan, J.C. Rice, A. Schaeffer, and T.M. Hooton Infectious Diseases Society of America Guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults Clin Infect Dis 40 2005 643 654
10. L.E. Nicolle Uncomplicated urinary tract infection in adults including uncomplicated pielonephritis Urol Clin North Am 35 2008 1 12 v
11. A.R. Ronald, and A.L. Patullo The natural history of urinary tract infection in adults Med Clin North Am 75 1991 299 312
12. S. Fiorante, F. López-Medrano, M. Lizasoain, A. Lalueza, R.S. Juan, A. Andrés, and et al. Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients Kidney Int 78 2010 774 781
13. X. Albert, I. Huertas, I.I. Pereiro, J. Sanfelix, V. Gosalbes, and C. Perrota Antibiotics for preventing recurrent urinary tract infection in non-pregnant women Cochrane Database Syst Rev 2014 CD001209
14. R. Parasuraman, K. Julian, and the AST Infectious Diseases Community of Practice Urinary tract infections in solid organ transplantation Am J Transplant 13 2013 327 336
15. J.M. García-Arenzana, and J.A. López-García Prostatitis, epididimitis y orquitis A. Ruiz, M. Guillén, Tratado SEIMC de Enfermedades Infecciosas y Microbiología Clínica 2005 Médica Panamericana Buenos Aires/Madrid 1241 1248
16. J.N. Krieger Prostatitis, epididimitis y orquitis Mandell Douglas Bennett Principles and practice of infectious diseases 6th ed. 2006 Elsevier España S.A. Madrid 1381 1386
17. M. Veroux, G. Giuffrida, D. Corona, M. Gagliano, V. Scriffignano, D. Vizcarra, and et al. Infective complications in renal allograft recipients: epidemiology and outcome Transplant Proc 40 2008 1873 1876
18. K.C. Abbott, J.D. Oliver 3rd, I. Hypolite, L.L. Lepler, A.D. Kirk, and et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States Am J Nephrol 21 2001 120 127
19. J.C. Rice, and N. Safdar Urinary tract infections in solid organ transplant recipients Am J Transplant 9 Suppl. 4 2009 S267 S272
20. J. Delgado, N. Calvo, A. Gomis, I. Perez-Flores, A. Rodríguez, N. Ridao, and et al. Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication Transplant Proc 42 2010 2944 2946
21. N. Safdar, W.R. Slattery, V. Knasinski, R.E. Gangnon, Z. Li, J.D. Pirsch, and et al. Predictors and outcomes of candiduria in renal transplant recipients Clin Infect Dis 40 2005 1413 1421
22. D. Kawecki, A. Kwiatkowski, A. Sawicka-Grzelak, M. Durlik, L. Paczek, A. Chmura, and et al. Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility Transplant Proc 43 2011 2991 2993
23. P. Muñoz Management of urinary tract infections and lymphocele in renal transplant recipients Clin Infect Dis 33 Suppl. 1 2001 S53 S57
24. K.C. Abbott, S.J. Swanson, E.R. Richter, E.M. Bohen, L.Y. Agodoa, T.G. Peters, and et al. Late urinary tract infection after renal transplantation in the United States Am J Kidney Dis 44 2004 353 362
25. R. Sorto, S.S. Irizar, G. Delgadillo, J. Alberú, R. Correa-Rotter, and L.E. Morales-Buenrostro Risk factors for urinary tract infections during the first year after kidney transplantation Transplant Proc 42 2010 280 281
26. W.E. Stamm Scientific and clinical challenges in the management of urinary tract infections Am J Med 113 Suppl. 1A 2002 1S 4S
27. B. Foxman Epidemiology of urinary tract infections: incidence, morbidity, and economics cost Am J Med 113 Suppl. 1A 2002 5S 13S
28. N.S. Kamath, G.T. John, N. Neelakantan, M.G. Kirubakaran, and C.K. Jacob Acute graft pyelonephritis following renal transplantation Transpl Infect Dis 8 2006 140 147
29. M. Giral, G. Pascuariello, G. Karam, M. Hourmant, D. Cantarovich, J. Dantal, and et al. Acute graft pyelonephritis and long-term kidney allograft outcome Kidney Int 61 2002 1880 1886
30. S.A. Fayek, J. Keenan, A. Haririan, M. Cooper, R.N. Barth, E. Schweitzer, and et al. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience Transplantation 93 2012 304 308
31. P.S. Almond, A. Matas, K. Gillingham, D.L. Dunn, W.D. Payne, P. Gores, and et al. Risk factors for chronic rejection in renal allograft recipients Transplantation 55 1993 752 756 [discussion 756-7]
32. P. Chordia, D. Schain, and L. Kayler Effects of ureteral stents on risk of bacteriuria in renal allograft recipients Transpl Infect Dis 15 2013 268 275
33. P. Chuang, C.R. Parikh, and A. Langone Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers Clin Transplant 19 2005 230 235
34. B.C. Fox, H.W. Sollinger, F.O. Belzer, and D.G. Maki A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis Am J Med 89 1990 255 274
35. K.O. Memikoglu, K. Keven, S. Sengul, Z. Soypacaci, S. Erturk, and B. Er-bay Urinary tract infections following renal transplantation: a single-center experience Transplant Proc 39 2007 3131 3134
36. P. Di Cocco, G. Orlando, C. Mazzotta, V. Rizza, M. D'Angelo, K. Clemente, and et al. Incidence of urinary tract infections caused by germs resistant to antibiotics commonly used after renal transplantation Transplant Proc 40 2008 1881 1884
37. F. López-Medrano, M. García-Bravo, J.M. Morales, A. Andrés, R. San Juan, M. Lizasoain, and et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction - results of a prospective cohort study Clin Infect Dis 46 2008 825 830
38. L. Linares, C. Cervera, F. Cofán, M.J. Ricart, N. Esforzado, V. Torregrosa, and et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation Transplant Proc 39 2007 2222 2224
39. H. Green, R. Rahamimov, U. Gafter, L. Leibovitci, and M. Paul Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis Transpl Infect Dis 13 2011 441 447
40. C. Rafat, S. Vimont, P.Y. Ancel, Y.C. Xu-Dubois, L. Mesnard, N. Ouali, and et al. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients Transpl Infect Dis 13 2011 344 352
41. E.B. El Amari, K. Hadaya, L. Buhler, T. Berney, P. Rohner, P.Y. Martin, and et al. Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients Nephrol Dial Transplant 26 2011 4109 4114
42. V. Audard, M. Amor, D. Desvaux, M. Pastural, C. Baron, R. Philippe, and et al. Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant Transplantation 80 2005 1128 1130
43. S. Fiorante, M. Fernández-Ruiz, F. López-Medrano, M. Lizasoain, A. Lalueza, J.M. Morales, and et al. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome Nephrol Dial Transplant 26 2011 1065 1073
44. W.E. Hoy, S.M. Kissel, R.B. Freeman, and W.A. Sterling Jr. Altered patterns of posttransplant urinary tract infections associated with perioperative antibiotics and curtailed catheterization Am J Kidney Dis 6 1985 212 216
45. N.E. Tolkoff-Rubin, A.B. Cosimi, P.S. Russell, and R.H. Rubin A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients Rev Infect Dis 4 1982 614 618
46. T.D. Batiuk, K.A. Bodziak, and M. Goldman Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers Clin Transplant 16 2002 1 8
47. D.G. Maki, B.C. Fox, J. Kuntz, H.W. Sollinger, and F.O. Belzer A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine J Lab Clin Med 119 1992 11 24
48. P.I. Hibberd, N.E. Tolkoff-Rubin, M. Doran, A. Delvecchio, A.B. Cosimi, F.L. Delmonico, and et al. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial Online J Curr Clin Trials 1922 August 11; Doc No 15
49. H.T. Khosroshahi, A.N. Mogaddam, and M.M. Shoja Efficacy of high-dose trimethoprim-sulfamethoxazole prophylaxis on early urinary tract infection after renal transplantation Transplant Proc 38 2006 2062 2064
50. M.S. Maddux, S.A. Veremis, W.D. Bauma, R. Pollak, and M.F. Mozes Effective prophylaxis of early post-transplant urinary tract infections (UTI) in the cyclosporine (CSA) era Transplant Proc 21 1 Part 2 1989 2108 2109
51. M. Moyses Neto, R.S. Costa, M.A. Reis, A.S. Ferraz, L.T. Saber, M.E. Batista, and et al. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients Clin Transplant 11 5 Part 1 1997 446 452
52. T.M. Hooton, R. Besser, B. Foxman, T.R. Fritsche, and L.E. Nicolle Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy Clin Infect Dis 39 2004 75 80
53. Multiply antibiotic-resistance Gram-negative bacteria Am J Transplant 4 Suppl. 10 2004 21 24
54. K.M. Killgore, K.L. March, and B.J. Guglielmo Risk factors for community-acquired ciprofloxacin-resistance Escherichia coli urinary tract infection Ann Pharmacother 38 2004 1148 1152
55. R.O. Darouiche, and R.A. Hull Bacterial interference for prevention of urinary tract infection: an overview J Spinal Cord Med 23 2000 136 141
56. Kidney Disease Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 Suppl. 3 2009 S1 S157
57. M. Säemann, and W.H. Hörl Urinary tract infection in renal transplant recipients Eur J Clin Invest 38 S2 2008 58 65
58. R. Yacoub, and N.K. Akl Urinary tract infections and asymptomatic bacteriuria in renal transplant recipients J Glob Infect Dis 3 2011 383 389
59. D.R. Snydman Post transplant microbiological surveillance Clin Infect Dis 33 Suppl. 1 2001 S22 S25
60. M. Franz, and H. Horl Common errors in diagnosis and management of urinary tract infection II: clinical management Nephrol Dial Transplant 14 1999 2754 2762
61. L.E. Nicolle Asymptomatic bacteriuria: when to screen and when to treat Infect Dis Clin North Am 17 2003 367 394
62. H. Green, R. Rahamimov, E. Goldberg, L. Leibovici, U. Gafter, J. Bishara, and et al. Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study Eur J Clin Microbiol Infect Dis 32 2013 127 131
63. M. Moradi, M. Abbasi, A. Moradi, A. Boskabadi, and A. Jalali Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients Urol J 2 2005 32 35
64. P.J.A. Griffin, and J.R. Salaman Urinary tract infections after renal transplantation: do they matter? Br Med J 1 1979 710 711
65. M. Ciszek, L. Paczek, I. Bartlomiejczyk, and K. Mucha Urine cytokines profile in renal transplant recipients with asymptomatic bacteriuria Transplantation 81 2006 1653 1657
66. J.C. Rice, T. Peng, Y.F. Kuo, S. Pendyala, L. Simmons, J. Boughton, and et al. Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors Am J Transplant 6 2006 2375 2383
67. P.J. Dupont, E. Psimenou, R. Lord, J.R. Buscombe, A.J. Hilson, and P. Sweny Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux Transplantation 84 2007 351 355
68. J. Origüen, F. López-Medrano, M.A. Pérez-Jacoiste, M. Fernández-Ruiz, A. Andrés, J.M. Aguado, and et al. Prospective comparative study of a strategy of systematic search and treatment versus no treatment of asymptomatic bacteriuria (AB) in kidney transplant (KT) recipients: preliminary results American Transplant Congress 2013 Abstract 252120
69. J. Coussement, and D. Abramowicz Should we treat asymptomatic bacteriuria after renal transplantation Nephrol Dial Transplant 29 2014 260 262
70. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamín Jr., T.F. Calandra, J.E. Edwards Jr., and et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clinical Infect Dis 48 2009 503 535
71. S.J. Rizvi, R. Chauhan, R. Gupta, and P. Modi Significance of pretransplant urinary tract infection in short-term renal allograft function and survival Transplant Proc 40 2008 1117 1118
72. S.A. Fischer, R.K. Averyb, and the AST Infectious Disease Community of PracticeAT Screening of donor and recipient prior to solid organ transplantation Am J Transplant 9 Suppl. 4 2009 S7 S18
73. A. Schaffner Pretransplant evaluation for infections in donors and recipients of solid organs Clin Infect Dis 33 Suppl. 1 2001 S9 S14
74. A. Silva, N. Rodig, C.P. Passerotti, P. Recabal, J.G. Borer, A.B. Retik, and et al. Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults J Urol 184 2010 1462 1467
75. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, E.C. Kim, and et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome Antimicrob Agents Chemother 49 2005 760 766
76. M.J. Schwaber, and Y. Carmeli Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis J Antimicrob Chemother 60 2007 913 920
77. C. Cervera, L. Linares, G. Bou, and A. Moreno Multidrug-resistant bacterial infection in solid organ transplant recipients Enferm Infecc Microbiol Clin 30 Suppl. 2 2012 40 48
78. F. Bert, B. Larroque, C. Paugam-Burtz, F. Dondero, F. Durand, E. Marcon, and et al. Pretransplant fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and infection after liver transplant, France Emerg Infect Dis 18 2012 908 916
79. H.S. Pinheiro, A.M. Mituiassu, M. Carminatti, A.M. Braga, and M.G. Bastos Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients Transplant Proc 42 2010 486 487
80. C. Silva, N. Afonso, F. Macário, R. Alves, and A. Mota Recurrent urinary tract infections in kidney transplant recipients Transplant Proc 45 2013 1092 1095
81. K.T. Bui, S. Metha, T.H. Khuu, D. Ross, M. Carlson, M.R. Leibowitz, and et al. Extended spectrum β-lactamase-producing Enterobacteriaceae infection in heart and lung transplant recipients and in mechanical circulatory support recipients Transplantation 97 2014 590 594
82. J.A. Martínez, J. Aguilar, M. Almela, F. Marco, A. Soriano, F. López, and et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia J Antimicrob Chemother 58 2006 1082 1085
83. S. Dewar, L.C. Reed, and R.J. Koerner Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria J Antimicrob Chemother 69 2014 303 308
84. L.E. Nicolle, and M.R. Mulvey Successful treatment of CTX-M ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam Scand J Infect Dis 39 2007 748 749
85. E. Titelman, A. Iversen, M. Kalin, and C.G. Giske Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae Microb Drug Resist 18 2012 189 192
86. A. Iravani, I. Klimberg, C. Briefer, C. Munera, S.F. Kowalsky, and R.M. Echols A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection J Antimicrob Chemother 43 Suppl. a 1999 67 75
87. G. Bonfiglio, R. Mattina, A. Lanzafame, E. Cammarata, G. Tempera Italian Medici Medicina Generale (MMG) Group Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study Chemotherapy 51 2005 162 166
88. N. Ceran, D. Mert, F.Y. Kocdogan, I. Erdem, R. Adalati, Ozyurek, and et al. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections J Infect Chemother 16 2010 424 430
89. M.E. Falagas, E.K. Vouloumanou, A.G. Togias, M. Karadima, A.M. Kapaskelis, P.I. Rafailidis, and et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials J Antimicrob Chemother 65 2010 1862 1877
90. D. Kavatha, H. Giamarellou, Z. Alexiou, N. Vlachogiannis, S. Pentea, T. Gozadinos, and et al. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women Antimicrob Agents Chemother 47 2003 897 900
91. T.M. Hooton, D. Scholes, K. Gupta, A.E. Stapleton, P.L. Roberts, and W.E. Stamm Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial JAMA 293 2005 949 955
92. A.P. Leigh, M.A. Nemeth, C.H. Keyserling, L.H. Hotary, and K.J. Tack Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection Clin Ther 22 2000 818 825
93. K. Gupta, T.M. Hooton, K.G. Naber, B. Wullt, R. Colgan, L.G. Miller, and et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Clin Infect Dis 52 2011 e103 e120
94. J.L. Arredondo-Garcia, R. Figueroa-Damian, A. Rosas, A. Jauregui, M. Corral, A. Costa, and et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study J Antimicrob Chemother 54 2004 840 843
95. D. Henry, W. Ellison, J. Sullivan, D.L. Mansfield, D.J. Magner, M.B. Dorr, and et al. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group Antimicrob Agents Chemother 42 1998 2262 2266
96. K.G. Naber, A. Bartnicki, W. Bischoff, M. Hanus, S. Milutinovic, F. van Belle, and et al. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections Int J Antimicrob Agents 23 Suppl. 1 2004 S41 S53
97. L.E. Nicolle, K.S. Madsen, G.O. Debeeck, E. Blochlinger, N. Borrild, J.P. Bru, and et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women Scand J Infect Dis 34 2002 487 492
98. M.A. Aldeyab, S. Harbarth, N. Vernaz, M.P. Kearney, M.G. Scott, F.W. Darwish Elhajji, and et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings Br J Clin Pharmacol 74 2012 171 179
99. G. Aubert, A. Carricajo, A.C. Vautrin, S. Guyomarc'h, N. Fonsale, D. Page, and et al. Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit J Hosp Infect 59 2005 83 89
100. T.M. Hooton Clinical practice. Uncomplicated urinary tract infection N Engl J Med 366 2012 1028 1037
101. T.C. Christiaens, M. De Meyere, G. Verschraegen, W. Peersman, S. Heytens, and J.M. De Maeseneer Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women Br J Gen Pract 52 2002 729 734
102. K. Gupta, T.M. Hooton, P.L. Roberts, and W.E. Stamm Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women Arch Intern Med 167 2007 2207 2212
103. G.E. Stein Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection Clin Ther 21 1999 1864 1872
104. M. Oplinger, and C.O. Andrews Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence Ann Pharmacother 47 2013 106 111
105. M.M. Meyer, and R.J. Meyer Nitrofurantoin-induced pulmonary hemorrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review of the literature J Urol 152 1994 938 940
106. D.A. Talan, W.E. Stamm, T.M. Hooton, G.J. Moran, T. Burke, A. Iravani, and et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial JAMA 283 2000 1583 1590
107. H.A. Klausner, P. Brown, J. Peterson, S. Kaul, M. Khashab, A.C. Fisher, and et al. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis Curr Med Res Opin 23 2007 2637 2645
108. J. Peterson, S. Kaul, M. Khashab, A.C. Fisher, and J.B. Kahn A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis Urology 71 2008 17 22
109. E. Machado, T.M. Coque, R. Canton, F. Baquero, J.C. Sousa, and L. Peixe Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme Antimicrob Agents Chemother 50 2006 3220 3221
110. A.S. Puerto, J.G. Fernandez, D. del Castillo Jde, M.J. Pino, and G.P. Angulo In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli Diagn Microbiol Infect Dis 54 2006 135 139
111. J. Rodríguez-Baño, J.C. Alcalá, J.M. Cisneros, F. Grill, A. Oliver, J.P. Horcajada, and et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli Arch Intern Med 168 2008 1897 1902
112. D. Sousa, L. Castelo-Corral, J.M. Gutiérrez-Urbón, F. Molina, B. López-Calvino, G. Bou, and et al. Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology J Antimicrob Chemother 68 2013 1917 1925
113. E. Elliott, A.J. Brink, J. van Greune, Z. Els, N. Woodford, J. Turton, and et al. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase Clin Infect Dis 42 2006 e95 e98
114. S.P. Hawser, S.K. Bouchillon, C. Lascols, M. Hackel, D.J. Hoban, R.E. Badal, and et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates Antimicrob Agents Chemother 55 2011 3917 3921
115. A. Poulou, E. Voulgari, G. Vrioni, V. Koumaki, G. Xidopoulos, V. Chatzipantazi, and et al. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone CARRYING an OmpK36 porin variant J Clin Microbiol 51 2013 3176 3182
116. T. Tängdén, M. Adler, O. Cars, L. Sandegren, and E. Löwdin Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model J Antimicrob Chemother 68 2013 1319 1326
117. S.P. Hawser, S.K. Bouchillon, C. Lascols, M. Hackel, D.J. Hoban, R.E. Badal, and et al. Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum beta-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009) Clin Microbiol Infect 18 2012 253 259
118. M.D. Bergamasco, M. Barroso, D. de Oliveira, R. Cipullo, J.C.M. Moreira, and C. Baia Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation Transpl Infect Dis 14 2012 198 205
119. C.J. Clancy, L. Chen, R.K. Shields, Y. Zhao, S. Cheng, K.D. Chavda, and et al. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients Am J Transplant 13 2013 2619 2633
120. M.J. Satlin, S.G. Jenkins, and T.J. Walsh The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies Clin Infect Dis 58 2014 1274 1283
121. J.S. Kalpoe, E. Sonnenberg, S.H. Factor, J. del Rio Martin, T. Schiano, G. Patel, and et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients Liver Transpl 18 2012 468 474
122. KPC-2 producing Klebsiella pneumoniae in renal transplant patients: a retrospective study Transpl Proc 45 2013 3389 3393
123. Y. Raviv, D. Shitrit, A. Amital, B. Fox, I. Bakal, R. Tauber, and et al. Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients Clin Transplant 26 2012 E388 E394
124. M.E. Falagas, P. Lourida, P. Poulikakos, P.I. Rafailidis, and G.S. Tansarli Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence Antimicrob Agents Chemother 58 2014 654 663
125. J. Rodríguez-Baño, J.M. Cisneros, N. Cobos-Trigueros, G. Fresco, C. Navarro-San Francisco, C. Gudiol, and et al. Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology Enferm Infecc Microbiol Clin 2014 10.1016/j.eimc.2014.11.009
126. G.L. Daikos, S. Tsaousi, L.S. Tzouvelekis, I. Anyfantis, M. Psichogiou, A. Argyropoulou, and et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems Antimicrob Agents Chemother 58 2014 2322 2328
127. M.M. Mostardeiro, C.A. Pereira, A.R. Marra, J.O. Pestana, and L.F. Camargo Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients Antimicrob Agents Chemother 57 2013 1442 1446
128. D. van Duin, C. van Delden, and the AST Infectious Diseases Community of Practice Multidrug-resistant Gram-negative bacteria infections in solid organ transplantation Am J Transplant 13 2013 31 41
129. G. Patel, D.R. Snydman, and the AST Infectious Diseases Community of Practice Vancomycin-resistant Enterococcus infections in solid organ transplantation Am J Transplant 13 2013 59 67
130. C.A. Arias, D. Panesso, D.M. McGrath, X. Qin, M.F. Mojica, C. Miller, and et al. Genetic basis for in vivo daptomycin resistance in enterococci N Engl J Med 365 2011 892 900
131. M. Sallee, C. Rafat, J.R. Zahar, B. Paulmier, J.P. Grunfeld, B. Knebelmann, and et al. Cyst infections in patients with autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 4 2009 1183 1189
132. W.M. Bennett, L. Elzinga, J.P. Pulliam, A.L. Rashad, and J.M. Barry Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease Am J Kidney Dis 6 1985 400 404
133. L.W. Elzinga, T.A. Golper, A.L. Rashad, M.E. Carr, and W.M. Bennett Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys Kidney Int 32 1987 884 888
134. A. Telenti, V.E. Torres, J.B. Gross Jr., R.E. Van Scoy, M.L. Brown, and R.R. Hattery Hepatic cyst infection in autosomal dominant polycystic kidney disease Mayo Clin Proc 65 1990 933 942
135. L. Hiyama, A. Tang, and L.G. Miller Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease Am J Kidney Dis 47 2006 e9 e13
136. L.W. Elzinga, T.A. Golper, A.L. Rashad, M.E. Carr, and W.M. Bennett Ciprofloxacin activity in cyst fluid from polycystic kidneys Antimicrob Agents Chemother 32 1988 844 847
137. S.J. Schwab, and M.E. Weaver Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease Am J Kidney Dis 7 1986 434 438
138. K. Charalabopoulos, G. Karachalios, D. Baltogiannis, A. Charalabopoulos, X. Giannakopoulos, and N. Sofikitis Penetration of antimicrobial agents into the prostate Chemotherapy 49 2003 269 279
139. B.A. Lipsky, I. Byren, and C.T. Hoey Treatment of bacterial prostatitis Clin Infect Dis 50 2010 1641 1652
140. R.H. Rubin, J.S. Wolfson, A.B. Cosimi, and N.E. Tolkoff-Rubin Infections in the renal transplant recipient Am J Med 70 1981 405 411
141. R.J. Hamshere, G.D. Chisholm, and R. Shackman Late urinary tract infection after renal transplantation Lancet 2 1974 793 794
142. A. Moreno, C. Cervera, J. Gavaldá, M. Rovira, R. de la Cámara, I. Jarque, and et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain Am J Transplant 7 2007 2579 2586
143. J.M. Ramos, P. García-Corbeira, J.M. Aguado, J.J. Plaza, and F. Soriano Nontyphoid Salmonella extraintestinal infections in renal transplant recipients Nephron 71 1995 489 490
144. Y. Samra, Y. Shaked, and M.K. Maier Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature Rev Infect Dis 8 1986 431 440
145. T. Sandberg, G. Skoog, A.B. Hermansson, G. Kahlmeter, N. Kuylenstierna, A. Lannergard, and et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial Lancet 380 2012 484 490
146. M. Sallée, C. Rafat, J.R. Zahar, B. Paulmier, J.P. Grünfeld, B. Knebelmann, and et al. Cyst infections in patients with autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 4 2009 1183 1189
147. F. Jouret, R. Lhommel, O. Devuyst, L. Annet, Y. Pirson, Z. Hassoun, and et al. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities Nephrol Dial Transplant 27 2012 3746 3751
148. J. Delgado, N. Calvo, A. Gomis, I. Pérez-Flores, A. Rodríguez, N. Ridao, and et al. Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication Transplant Proc 42 2010 2944 2946
149. J.F. Fisher, J.D. Sobel, C.A. Kauffman, and C.A. Newman Candida urinary tract infections - treatment Clin Infect Dis 52 Suppl. 6 2011 S457 S466
150. S.G. Revankar, M.S. Hasan, V.S. Revankar, and J.D. Sobel Long-term follow-up of patients with candiduria Eur J Clin Microbiol Infect Dis 30 2011 137 140
151. J.D. Sobel, C.A. Kauffman, D. McKinsey, M. Zervos, J.A. Vazquez, A.V.V. Karchmer, and et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group Clin Infect Dis 30 2000 19 24
152. C.A. Kauffman, J.F. Fisher, J.D. Sobel, and C.A. Newman Candida urinary tract infections - diagnosis Clin Infect Dis 52 Suppl 6 2011 S452 S456
153. C. Rodríguez, P. Muñoz, M. Rodríguez-Creixems, J.F. Yañez, J. Palomo, and E. Bouza Bloodstream infections among heart transplant recipients Transplantation 81 2006 384 391
154. P. Muñoz, A. Burillo, and E. Bouza Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit Int J Antimicrob Agents 15 2000 83 90
155. J.M. Aguado, I. Ruiz-Camps, P. Muñoz, J. Mensa, B. Almirante, L. Vázquez, and et al. Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update Enferm Infecc Microbiol Clin 29 2011 345 361
156. O.A. Cornely, M. Bassetti, T. Calandra, J. Garbino, B.J. Kullberg, O. Lortholary, and et al. ESCMID∗guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients Clin Microbiol Infect 18 Suppl. 7 2012 19 37
157. M. Veroux, D. Corona, G. Giuffrida, M. Gagliano, T. Tallarita, A. Giaquinta, and et al. Acute renal failure due to ureteral obstruction in a kidney transplant recipient with Candida albicans contamination of preservation fluid Transpl Infect Dis 11 2009 266 268
158. S.M. Arend, E.J. Kuijper, B.J. de Vaal, J.W. de Fijter, and J.W. van't Wout Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient Eur J Clin Microbiol Infect Dis 25 2006 43 45
159. L.P. Nicod, J.C. Pache, and N. Howarth Fungal infections in transplant recipients Eur Respir J 17 2001 133 140
160. F. Lefevre, E. Renoult, J. Hubert, M. Kessler, D. Regent, and M. Claudon Bladder candidosis after renal transplantation: contribution of ultrasonography J Radiol 81 2000 457 459
161. R.C. Ireton, J.N. Krieger, T.G. Rudd, and T.L. Marchioro Percutaneous endoscopic treatment of fungus ball obstruction in a renal allograft Transplantation 39 1985 453 454
162. Y. Walzer, and R.A. Bear Ureteral obstruction of renal transplant due to ureteral candidiasis Urology 21 1983 295 297
163. L. Albano, S. Bretagne, M.F. Mamzer-Bruneel, I. Kacso, M. Desuos-Ollivier, P. Guerrini, and et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France Clin Infect Dis 48 2009 194 202
164. N. Singh, S. Huprikar, S.D. Burdette, M.I. Morris, J.E. Blair, and L.J. Wheat Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice Am J Transplant 12 2012 2414 2428
165. J. Fortún, P. Martín-Dávila, M. Montejo, P. Muñoz, J.M. Cisneros, A. Ramos, and et al. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients Transplantation 87 2009 424 435
166. F.F. Tuon, V.S. Amato, and S.R. Penteado Filho Bladder irrigation with amphotericin B and fungal urinary tract infection - systematic review with meta-analysis Int J Infect Dis 13 2009 701 706
167. J. Fisher, G. Mayhall, R. Duma, S. Shadomy, J. Shadomy, and C. Watlington Fungus balls of the urinary tract South Med J 72 1979 1281 1284 7
168. O. Vazquez-Tsuji, T. Campos-Rivera, H. Ahumada-Mendoza, A. Rondan-Zarate, and I. Martinez-Barbabosa Renal ultrasonography and detection of pseudomycelium in urine as means of diagnosis of renal fungus balls in neonates Mycopathologia 159 2005 331 337
169. B. Baetz-Greenwalt, B. Debaz, and M.L. Kumar Bladder fungus ball: a reversible cause of neonatal obstructive uropathy Pediatrics 81 1988 826 829
170. J.F. Fisher, K. Woeltje, A. Espinel-Ingroff, J. Stanfield, and J.T. DiPiro Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience Clin Microbiol Infect 9 2003 1024 1027
171. H.S. Leu, and C.T. Huang Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study Clin Infect Dis 20 1995 1152 1157
172. S. Schelenz, and C.N. Ross Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection BMC Infect Dis 6 2006 126
173. F. Walther, U. Kaben, M. Radke, R. Terpe, and H.J. Stolpe Candidosis of the urinary tract with padding phenomenon of the renal pelvises in an infant with obstructive uropathy Mycoses 37 1994 291 294
174. E.D. Ralph, K.R. Barber, and C.W. Grant Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans Am J Nephrol 11 1991 118 122
175. M.J. Hepburn, G.J. Pennick, D.A. Sutton, G.E. Crawford, and J.H. Jorgensen Candida krusei renal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome Med Mycol 41 2003 163 165
176. J.D. Sobel, S.K. Bradshaw, C.J. Lipka, and N.A. Kartsonis Caspofungin in the treatment of symptomatic candiduria Clin Infect Dis 44 2007 e46 e49
177. S. Weichert, K. Reinshagen, K. Zahn, G. Geginat, A. Dietz, A.K. Kilian, and et al. Candidiasis caused by Candida kefyr in a neonate: case report BMC Infect Dis 12 2012 61
178. G.J. Wise, P.J. Kozinn, and P. Goldberg Amphotericin B as a urologic irrigant in the management of noninvasive candiduria J Urol 128 1982 82 84
179. G.J. Wise Re: Continuous versus intermittent bladder irrigation of amphotericin B for the treatment of candiduria J Urol 156 2 Pt 1 1996 485
180. J.M. Aguado, E. Varo, P. Usetti, J.C. Pozo, A. Moreno, M. Catalán, and et al. Safety of anidulafungin in solid organ transplant recipients Liver Transpl 18 2012 680 685
181. J.D. Martinez-Pajares, M.C. Martinez-Ferriz, D. Moreno-Perez, M. Garcia-Ramirez, S. Martin-Carballido, and P. Blanch-Iribarne Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn J Med Microbiol 59 Pt 3 2010 367 369
182. G.J. Wise, P.J. Kozinn, and P. Goldberg Flucytosine in the management of genitourinary candidiasis: 5 years of experience J Urol 124 1980 70 72
183. A. Dinckan, I. Aliosmanoglu, H. Kocak, F. Gunseren, A. Mesci, Z. Ertug, and et al. Surgical correction of vesico-ureteric reflux for recurrent febrile urinary tract infections after kidney transplantation BJU Int 112 2013 366 371
184. J. Gołębiewska, A. Dębska-͆lizień, J. Komarnicka, A. Samet, and B. Rutkowski Urinary tract infections in renal transplant recipients Transplant Proc 43 2011 2985 2990
185. J.H. Lim, J.H. Cho, J.H. Lee, Y.J. Park, S. Jin, G.Y. Park, and et al. Risk factors for recurrent urinary tract infection in kidney transplant recipients Transplant Proc 45 2013 1584 1589
186. E.J. Ariza-Heredia, E.N. Beam, T.G. Lesnick, W.K. Kremers, F.G. Cosio, and R.R. Razonable Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis Ann Transplant 18 2013 195 204
187. T. Mazulli Diagnosis and management of simple and complicated urinary tract infections Can J Urol 19 2012 42 48
188. S.E. Geerlings, M.A. Beerepoot, and J.M. Prins Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies Infect Dis Clin North Am 28 2014 135 147
189. R.M. De Souza, and J. Olsburgh Urinary tract infection in the renal transplant patient Nat Clin Pract Nephrol 4 2008 252 264
190. L.E. Nicolle Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury Infect Dis Clin North Am 28 2014 91 104
191. R.M. De Souza, A. Prachalias, P. Srinivasan, M. O'Doherty, and J. Olsburgh Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management Transplant Proc 41 2009 1942 1945
192. P.D. Brown, A. Freeman, and B. Foxman Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan Clin Infect Dis 34 2002 1061 1066
193. J.P. Metlay, B.L. Strom, and D.A. Asch Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections J Antimicrob Chemother 51 2003 963 970
194. S. Hillier, Z. Roberts, F. Dunstan, C. Butler, A. Howard, and S. Palmer Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study J Antimicrob Chemother 60 2007 92 99
195. D.A. Castañeda, K. León, R. Martín, L. López, H. Pérez, and E. Lozano Urinary tract infection and kidney transplantation: a review of diagnosis, causes, and current clinical approach Transplant Proc 45 2013 1590 1592
196. N. Pagonas, J. Hörstrup, D. Schmidt, P. Benz, R. Schindler, P. Reinke, and et al. Prophylaxis of recurrent urinary tract infection after renal transplantation by cranberry juice and l-methionine Transplant Proc 44 2012 3017 3021
197. A.E. Stapleton, J. Dziura, T.M. Hooton, M.E. Cox, Y. Yarova-Yarovaya, S. Chen, and et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial Mayo Clin Proc 87 2012 143 150
198. C. Perrotta, M. Aznar, R. Mejia, X. Albert, and C.W. Ng Oestrogens for preventing recurrent urinary tract infection in postmenopausal women Obstet Gynecol 112 2008 689 690
199. J.R. Lee, H. Bang, D. Dadhania, C. Hartono, M.J. Aull, M. Satlin, and et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients Transplantation 96 2013 732 738
200. V. Müller, G. Becker, M. Delfs, K.H. Albrecht, T. Philipp, and U. Heemann Do urinary tract infections trigger chronic kidney transplant rejection in man J Urol 159 1998 1826 1829
201. V.R. Dharnidharka, L.Y. Agodoa, and K.C. Abbott Effects of urinary tract infection on outcomes after renal transplantation in children Clin J Am SocNephrol 2 2007 100 106
202. S. Barbouch, M. Cherif, M. Ounissi, C. Karoui, S. Mzoughi, F.B. Hamida, and et al. Urinary tract infections following renal transplantation: a single-center experience Saudi J Kidney Dis Transpl 23 2012 1311 1314
203. C.I. Esezobor, P. Nourse, and P. Gajjar Urinary tract infection following kidney transplantation: frequency, risk factors and graft function Pediatr Nephrol 27 2012 651 657
204. R. Rivera-Sánchez, D. Delgado-Ochoa, R.R. Flores-Paz, E.E. García-Jiménez, R. Espinosa-Hernández, A.A. Bazan-Borges, and et al. Prospective study of UTI surveillance after kidney transplantation BMC Infect Dis 10 2010 245 251
205. J.A. Akoh, and T. Rana Effect of ureteric stents on urological infection and graft function following renal transplantation World J Transplant 3 2013 1 6
206. E.J. Ariza-Heredia, E.N. Beam, T.G. Lesnick, F.G. Cosio, W.K. Kremers, and R.R. Razonable Impact of urinary tract infection on allograft function after kidney transplantation Clin Transplant 28 2014 683 690
207. S. Berdaguer, J. Bautista, M. Brunet, and J.M. Cisneros Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients Enferm Infecc Microbiol Clin 30 Suppl. 2 2012 86 92
208. A. Eer Term, A.J. Hoitsma, and R.A. Koene Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients Transplantation 42 1986 220 221
209. J.M. Hows, P.M. Chipping, S. Fairhead, J. Smith, A. Baughan, and E.C. Gordon-Smith Nephrotoxicity in bone marrow transplant recipients treated with cyclosporine A Br J Haematol 54 1983 69 78
210. F. Jahansouz, J.M. Kriett, C.M. Smith, and S.W. Jamieson Potentiation of cyclosporin nephrotoxicity by nafcillin in lung transplant recipients Transplantation 55 1993 1045 1048
211. R. Borrows, G. Chusney, M. Loucaidou, A. James, J. Van Tromp, T. Cairns, and et al. The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy based mycophenolate mofetil in renal transplantation Ther Drug Monit 29 2007 122 126
212. Novartis Spain Sanndimmun Neoral (cyclosporine microemulsion). Spanish Summary of product characteristics 2011
213. E. Dodds-Ashley Management of drug and food interactions with azole antifungal agents in transplant recipients Pharmacotherapy 30 2010 842 854
214. Rapamune in: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000273/WC500046437.pdf.
215. Everolimus in: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/001038/WC500022814.pdf.
216. Voriconazole in: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000387/WC500049756.pdf.
217. Posaconazol in: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000610/WC500037784.pdf.
218. G. Eschenauer, and D.D. DePestel Carver PL. Comparison of echinocandin antifungals Ther Clin Risk Manag 3 2007 71 97